S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Abbott Laboratories Outlook is Healthy: Buy the Dip
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter

Cadrenal Therapeutics (CVKD) Short Interest Ratio & Short Volume

$0.42
+0.03 (+7.66%)
(As of 04/17/2024 ET)

Cadrenal Therapeutics Short Interest Data

Current Short Volume
42,000 shares
Previous Short Volume
21,900 shares
Change Vs. Previous Month
+91.78%
Dollar Volume Sold Short
$25,620.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
March 31, 2024
Outstanding Shares
16,010,000 shares
Float Size
8,480,000 shares
Short Percent of Float
0.50%
Today's Trading Volume
165,389 shares
Average Trading Volume
468,483 shares
Today's Volume Vs. Average
35%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cadrenal Therapeutics ?

Sign up to receive the latest short interest report for Cadrenal Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CVKD Short Interest Over Time

CVKD Days to Cover Over Time

CVKD Percentage of Float Shorted Over Time

Cadrenal Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202442,000 shares $25,620.00 +91.8%0.5%0.1 $0.61
3/15/202421,900 shares $12,877.20 +204.2%0.4%0.1 $0.59
2/29/20247,200 shares $5,068.80 -69.8%0.1%0 $0.70
2/15/202423,800 shares $18,566.38 -87.9%0.4%0.1 $0.78
1/31/2024196,700 shares $357,994.00 +389.3%3.6%0.6 $1.82
1/15/202440,200 shares $30,109.80 -38.7%0.7%0.3 $0.75
12/31/202365,600 shares $48,537.37 +28.9%1.2%0.9 $0.74
12/15/202350,900 shares $25,959.00 +50.6%0.9%0.9 $0.51
11/30/202333,800 shares $15,548.00 +38.5%0.6%0.9 $0.46
11/15/202324,400 shares $11,948.68 +101.7%0.5%0.5 $0.49
10/31/202312,100 shares $5,372.40 -63.4%0.3%0.2 $0.44
10/15/202333,100 shares $20,525.31 +126.7%0.7%0.5 $0.62
9/30/202314,600 shares $9,929.46 +1.4%0.3%0 $0.68
9/15/202314,400 shares $11,520.00 +65.5%0.3%0 $0.80
8/31/20238,700 shares $6,699.00 -82.3%0.2%0 $0.77
8/15/202349,100 shares $37,266.85 +16.4%1.2%0.1 $0.76
7/31/202342,200 shares $35,870.00 -90.2%1.4%0.1 $0.85
7/15/2023430,800 shares $555,688.92 +491.0%14.6%1.1 $1.29
6/30/202372,900 shares $110,079.00 +9.3%2.5%0.2 $1.51
6/15/202366,700 shares $101,384.00 -3.8%2.3%2.1 $1.52
5/31/202369,300 shares $98,406.00 -14.7%2.4%1.8 $1.42
5/15/202381,200 shares $114,492.00 No Change2.8%1.8 $1.41

CVKD Short Interest - Frequently Asked Questions

What is Cadrenal Therapeutics' current short interest?

Short interest is the volume of Cadrenal Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 42,000 shares of CVKD short. 0.50% of Cadrenal Therapeutics' shares are currently sold short. Learn More on Cadrenal Therapeutics' current short interest.

What is a good short interest percentage for Cadrenal Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.50% of Cadrenal Therapeutics' floating shares are currently sold short.

Is Cadrenal Therapeutics' short interest increasing or decreasing?

Cadrenal Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 42,000 shares, an increase of 91.8% from the previous total of 21,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cadrenal Therapeutics' float size?

Cadrenal Therapeutics currently has issued a total of 16,010,000 shares. Some of Cadrenal Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cadrenal Therapeutics currently has a public float of 8,480,000 shares.

How does Cadrenal Therapeutics' short interest compare to its competitors?

0.50% of Cadrenal Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cadrenal Therapeutics: Ainos, Inc. (4.81%), Xenetic Biosciences Inc (0.14%), First Wave BioPharma, Inc. (3.04%), Protagenic Therapeutics, Inc. (0.32%), Hoth Therapeutics, Inc. (5.00%), Shuttle Pharmaceuticals Holdings, Inc. (0.72%), Vaccinex, Inc. (1.17%), Enveric Biosciences, Inc. (4.23%), Avenue Therapeutics, Inc. (0.64%), Sunshine Biopharma, Inc. (0.77%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Cadrenal Therapeutics stock?

Short selling CVKD is an investing strategy that aims to generate trading profit from Cadrenal Therapeutics as its price is falling. CVKD shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cadrenal Therapeutics?

A short squeeze for Cadrenal Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CVKD, which in turn drives the price of the stock up even further.

How often is Cadrenal Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CVKD, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CVKD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners